FDA
India leads on non-animal testing and its draft lab animal rules threaten to undo that
India's draft Prevention of Cruelty to Animals Rules 2026 proposes significant changes to animal research regulations and oversight. It allows for harsher experimental practices that could cause severe suffering to animals. Local committees would gain power to approve experiments without thorough central review, raising concerns about ethical standards. This shift contradicts the existing legal framework established by the Prevention of Cruelty to Animals Act 1960.
Emcure Pharma shares hit 10% upper circuit after FY27 guidance hike; Jefferies raises target price by 8%
Emcure Pharma shares hit a 10% upper circuit after strong Q2 FY27 results prompted the company to raise its full-year growth guidance. Brokerages turned more positive, citing robust international business, improving domestic growth and a strong product pipeline.
Stop the price scam in our hospitals
A recent investigation in Maharashtra has shed light on concerning price hikes for medical supplies charged to patients. Items such as IV infusion sets have seen astronomical price increases, exceeding 2,800% over wholesale prices. Regulatory agencies have recognized that they lack jurisdiction over the pricing of medical disposables, amplifying worries about the potential for patient exploitation.
FDA collects samples of Patanjali cow ghee for laboratory testing
Patanjali Foods Ltd has reported that food safety officials collected samples of its Cow Ghee for testing. The company emphasizes that no authenticated report has confirmed any quality standard violations. Patanjali Foods stated that it is cooperating with the authorities regarding this issue. Additionally, the company remains committed to product quality and consumer safety. Further disclosures will be made as material developments arise in accordance with regulations.
Blood pressure drug recall: FDA flags thousands of bottles after pills fail quality tests; here's what to check
A major recall has been initiated for certain blood pressure medications produced by Macleods Pharma USA. Patients are urged to verify their medications against specific lot numbers and reach out to their pharmacists. The FDA indicates that this recall stems from issues with dissolution specifications. Failure to comply with proper guidelines could pose serious health risks from unmanaged hypertension.
Maharashtra FDA suspends 19 food licences; acts against Patanjali distributor over 'adulteration'
In a recent operation, the Maharashtra FDA suspended licenses of 19 food business operators for violations. They seized food articles worth over Rs 9 crore across multiple divisions in the state. This included significant amounts of Patanjali cow ghee found to be misbranded and adulterated. Further, the FDA registered FIRs, arrested several individuals, and sealed multiple establishments for serious hygiene issues.
- Go To Page 1
Wockhardt expands novel antibiotic Miqnaf's access; Q2 revenue rises 24%
Wockhardt has expanded its marketing access for Miqnaf in India following the removal of a supply condition. The company's biotechnology sector recorded significant revenue growth, indicating strong demand for its products. Zaynich received US FDA approval for complicated urinary tract infections, serving as a milestone for Indian pharmaceuticals.
Ajay Devgn's Vimal Elaichi ad controversy: FDA chief Tukaram Munde says proceedings will continue despite Drishyam 3 actor's High Court plea
Ajay Devgn has filed a petition with the Bombay High Court in response to a notice from the Maharashtra FDA regarding his appearance in Vimal Elaichi ads. The FDA contends that these ads promote a banned product. Commissioner Tukaram Munde affirmed that legal procedures will be followed. Read on!
UC innovations make TIME’s Best Inventions of 2026: How a pancreatic cancer drug and smarter wheelchair are changing lives?
From a pancreatic cancer drug that targets KRAS mutations to a smarter power wheelchair, University of California research is reaching beyond laboratories. Daraxonrasib, developed from discoveries at UCSF, received FDA approval in August. Meanwhile, UC Berkeley alumnus Tony Hong’s Strutt ev¹ uses sensors and voice controls to make everyday mobility easier.
'Mad Max' actor Richard Norton ignored nurse's warning about peptide treatment which he began days before his sudden death last year
Richard Norton, the Australian actor known for his work in films like 'Mad Max', passed away at 75. Prior to his death, he was undergoing peptide therapy that was recently initiated. Despite warnings, he took double the prescribed dosage of the peptides, leading to severe health complications. After collapsing, he received medical attention but tragically died days later.
UP CEO warns DEOs of action over voter roll errors, pending applications; orders daily monitoring
The Uttar Pradesh Chief Electoral Officer's office has issued warnings to District Election Officers regarding errors in electoral rolls. DEOs must monitor voter application processing and ensure no applications remain pending unnecessarily. Regular reviews of subordinate officials and their tasks are mandatory to maintain accountability. Complaints related to electoral rolls must be addressed promptly and satisfactorily, ensuring quality disposal.
4 FDA officials suspended over alleged unauthorised raids in Pune, 21 others to face inquiry
Four officials from the Maharashtra Food and Drug Administration have been suspended for conducting unauthorized raids. The Chief Minister approved this action following allegations regarding the officials' misconduct. A departmental inquiry is also being initiated against 21 other officials involved in the matter. This inquiry will investigate the actions of officials from the Thane and Pune divisions. Further action will be determined based on the findings of this investigation.
Actor Ajay Devgn moves Bombay High Court against FDA notice over Vimal Elaichi ads
Ajay Devgn has filed a petition in the Bombay High Court against the FDA's show-cause notice. The notice involves his advertisements for 'Vimal Elaichi', linked to banned products in Maharashtra. FDA Commissioner Tukaram Mundhe confirmed completed investigations regarding violations by several actors. Similar notices were issued to Shah Rukh Khan and Tiger Shroff for the same reason. The court is scheduled to hear the matter on November 4.
Pan masala ad proceedings against 3 actors complete, matter up for adjudication next: FDA chief
Maharashtra FDA has completed its investigation into actors Shah Rukh Khan, Ajay Devgn and Tiger Shroff over alleged violations of state rules through Vimal Pan Masala advertisements. The matter will be referred for adjudication next week, with the regulator proceeding despite Devgn approaching the Bombay High Court.
Sun Pharma ordered to halt eye drug production at Assam plant over quality lapses: Report
Indian regulators have ordered Sun Pharmaceutical Industries to stop manufacturing ophthalmic products at the Assam facility. This decision followed the discovery of failures in the company's quality management system. A joint inspection cited lapses that affected drug safety and quality, leading to a recall of several eye-drop brands. Significant adverse cases have raised concerns regarding product contamination, prompting further investigation.
Butter Recall: Miyoko’s Creamery plant-based butter pulled from stores in 10 states over contamination concerns-here's how to identify the product being recalled
Miyoko’s Creamery European Style Salted Plant Milk Butter has been recalled in ten US states due to contamination concerns. The FDA reported possible yeast, mold, and E. coli in the affected product. Around 1,304 cases of the 8-ounce butter are involved, impacting several states including Florida and New Jersey. Consumers are advised to check packaging details to determine if they have the recalled butter.
Anthropic's Claude cut Enveda's drug records' review time by 89%
Colorado-based biotechnology company Enveda developed a CMC Document Processor to help reviewers identify errors, inconsistencies and potential quality issues across these records.
Cipla sets sights on first-wave gains from rollout of Keytruda Biosimilar
Cipla has partnered with Qilu Pharmaceutical to commercialize a biosimilar of Keytruda, which is a major cancer treatment. The patent for this drug is expected to expire around 2029, allowing for potential market entry. Cipla anticipates capturing a significant share of this lucrative market segment after the launch. Additionally, the company reported a 35% decline in consolidated net profit in the September quarter.
Walmart canned fruit cocktail recalled in Alabama, Arizona, Louisiana, Pennsylvania, Washington sparks alarm over lead contamination: What to do if you have it at home
Over 44,000 cans of Great Value Fruit Cocktail are recalled due to potential lead contamination concerns. The recall, initiated by Pacific Coast Producers, began on October 1, 2026, and classified as a Class II recall. Consumers should check for specific product details to determine if their canned fruit is affected. Those with recalled products should not consume them and return them for a possible refund.
Lord’s Mark Industries Limited becomes Asia’s first company to secure multiple US FDA registrations for 200+ surgical and hygiene products; US exports to begin in December
Silvassa manufacturing expansion completed ahead of schedule as the company prepares to expand its international footprint across the United States and South America
Mark Cuban says AI hack agents are like cockroaches, but can be controlled
Cuban, famous for his role on business reality show "Shark Tank" and his involvement in the Dallas Mavericks NBA team, ventured into healthcare when he started the online pharmacy Cost Plus Drug Company in 2022 with a standard pricing scheme: the cost it pays for the drug, plus 15%.
FDA recalls 17 toothpaste varieties nationwide, affecting over 4 million tubes, including children's flavors and whitening products
Over 4 million tubes of toothpaste have been recalled by the FDA due to significant violations of Good Manufacturing Practices, predominantly affecting the Brush Buddies brand, especially children's items. Initiated by Pritam International Private Limited on September 10, the recall has been classified as Class II by the FDA, suggesting possible health risks. Consumers are strongly advised to consult the FDA website for the comprehensive list of impacted products.
US FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatment
Hibsago, GSK's new hepatitis B treatment, recently secured approval from the US FDA, allowing patients to better manage their condition after therapy. This approval is vital as GSK aims for annual revenues of over £40 billion by 2031. The drug is already approved in Japan and is being assessed in China and Europe. Collaboration with Ionis Pharmaceuticals means they will receive milestone payments.
As weight-loss drug users turn to dietary supplements, doctors, regulators raise flags
The growing use of GLP-1 weight-loss drugs such as Ozempic and Wegovy is driving demand for dietary supplements in the US, as users seek to manage side effects including nausea, fatigue and constipation. Supplement sales exceeded $74 billion in 2025, while TikTok Shop generated more than $1 billion in supplement sales.
FDA seizes nearly 9.5 tonnes of paneer, khoya ahead of Diwali in Pune
The FDA has seized approximately 9.5 tonnes of paneer and khoya in Pune before Diwali. This seizure is significant as demand for dairy products typically rises during the festive season. The Maharashtra FDA is conducting increased inspections of food establishments as part of its food safety initiative.
Reliance Retail faces FDA crackdown again; action also on Blinkit-linked facility
Maharashtra Food and Drug Administration suspended the licenses of Reliance Retail warehouses after inspections showed safety violations. The inspections revealed issues such as rodent infestation, improper storage, and expired products. In another facility linked to Blinkit, cold-room temperatures exceeded safe limits, and employees lacked necessary food safety training. The FDA registered FIRs and seized a significant quantity of expired products.
FDA suspends licences of warehouses of Reliance Consumer, Reliance Retail, Blinkit, Zomato Hyperpure
Maharashtra FDA has taken action against five warehouses for selling expired food products worth over Rs 48 lakh. Inspections revealed serious hygiene issues, including rodent infestations and lack of proper documentation. Warehouses operated by Reliance, Zomato Hyperpure, and Blinkit were found violating safety protocols significantly. Two unlicensed establishments were also shut down for storing and selling expired products.
Expired food back on sale? Reliance Consumer, Zomato, Blinkit under Maharashtra FDA scanner
FIR has been filed against officials of Reliance Consumer Products and Zomato Hyperpure. This action follows food stock seizures worth Rs 48 lakh for expired products during an FDA crackdown. The authorities conducted operations across Thane and Pune, uncovering the diversion of expired food through various agencies. Multiple individuals from involved companies were named in the FIR under food safety regulations.
Domino's Pizza outlets among 25 food establishments facing licence suspension in Maharashtra: FDA seizes 81,330 kg of food worth Rs 1.73 crore
Maharashtra’s Food and Drug Administration (FDA) has suspended the licences of 25 food establishments and four edible oil and spice manufacturing units during a statewide crackdown on food safety violations. Six Domino’s Pizza outlets in Pune division were among those affected. The FDA also seized around 81,330 kg of suspected substandard, adulterated or mislabelled food products worth Rs 1.73 crore from 37 establishments across six divisions.
Load More
